Navigation Links
New tests provide new insight into why patients are in heart failure
Date:3/31/2009

AUGUSTA, Ga. A failing heart makes a lot of a hormone needed to eliminate the excess salt and water bloating the body but not enough of the enzyme needed to activate it, researchers say.

Using novel assays they developed, Medical College of Georgia researchers found people in heart failure have less of the enzyme corin needed to activate pro-ANP, or pro-atrial natriuretic peptide, a hormone made by heart muscle cells that, when active, helps reduce extra sodium and fluid that tax the cardiovascular system.

Low corin levels help explain why the heart's natural attempt to save itself is often thwarted in heart failure and researchers hope the new tests they developed can help identify those people.

"The question is always: If you have so much of this hormone that is supposed to increase diuresis, why are patients still in heart failure with all this fluid in their lungs?" says Dr. Uzoma Ibebuogu, cardiology fellow at the Medical College of Georgia.

Dr. Ibebuogu presented the findings at the American College of Cardiology Congress March 28-31 in Orlando where he was among five finalists for the Young Investigator Award.

When he and colleagues Drs. Guy Reed and Inna Gladysheva compared 14 patients in heart failure to 16 people with healthy hearts, they found those in heart failure had about 80 percent less corin. Their assays enabled measurement of corin as well as active ANP levels instead of only the total pro-ANP levels measured by current technology.

Their findings indicate that low corin levels may be an indicator of heart failure or even people at risk for the condition diagnosed in more than a half million Americans annually, says Dr. Gladysheva, cardiovascular researcher in the MCG School of Medicine.

Heart failure is becoming increasingly common as people survive heart attacks but live with heart muscles that are too weak to contract and/or relax properly. Blood comes into the right side of the heart from the body then to the lungs then back to the left side of the heart which pumps it out to the body. In heart failure, fluid backs up in the lungs and the rest of the body, causing swelling and making it hard to breathe. Patients often require frequent hospitalization and five-year survival rates are about 50 percent.

Treatment includes lifestyle changes such as losing weight, restricting sodium and drug therapy such as diuretics, to help kidneys eliminate excess fluid and sodium. More recently a substance similar to ANP, called brain natriuretic peptide, or BNP, also is being used.

As with pro-ANP, a heart experiencing failure makes more BNP, which scientists believe also plays a role in ridding the body of excess fluid and sodium.

But experience is showing the drug only helps some patients and MCG researchers suspect their new tests can better identify which ones. Because even if patients have enough corin and consequently enough active ANP or BNP there can still be problems with activation of downstream signals that ultimately tell the kidneys to increase elimination of salt and fluids.

At the other end of the spectrum, some patients Dr. Ibebuogu sees with weak heart muscles don't experience heart failure symptoms. "Maybe they are making enough corin to take care of themselves," he theorizes. He and Dr. Gladysheva plan to find out by comparing corin levels in these individuals to those with symptoms. They'll also explore whether a damaged heart makes less corin and if a corin substitute could activate more ANP.

MCG researchers also want to use their assays to look at levels of active ANP and corin in a larger number of patients to determine whether corin levels are a good predictor/indicator of heart failure. "Corin levels were low in heart failure patients but we can't say when they dropped," Dr. Gladysheva says. "Was it when they started developing heart failure or is it genetic?"

A recombinant protein also called corin identified in the late 1990s helped solve the mystery of how pro-ANP got cleaved into the active state. That got Dr. Gladysheva wondering about the natural protein activator. She used antibodies to the recombinant protein to find the natural corin on the surface of heart cells, or cardiomyocytes. She later showed that corin and pro-ANP co-exist in the same heart cells in research published in Journal of Molecular and Cellular Cardiology in 2008.

That led to further exploration of why the heart's attempt to save itself from failure seems to fail so often and MCG researchers exploring their theory that corin levels might sometimes be to blame.


'/>"/>

Contact: Toni Baker
tbaker@mcg.edu
706-721-4421
Medical College of Georgia
Source:Eurekalert  

Related medicine news :

1. Coalition for 21st Century Medicine Endorses Patient Access to Critical Lab Tests Act
2. GeoFitness Physical/Mental Stimulus Plan Helps Increase Results in School State Standardized Tests
3. ICW Master Patient Index Passes HITSP Certification and IHE Tests
4. Cancer Screening Tests Could Do More Harm Than Good: Readers Digest April Cover Story
5. Mercy Integrated Labs Implements PNA FISH(R) Tests to Help Clinicians Provide Best Care for Patients With Bloodstream Infections
6. FDA Approves Two Hologic HPV Tests
7. Combo of Tests Might Spot Ovarian Cancer Early
8. Upcoming World Kidney Day Underscores Role of Low-Cost Lab Tests in Combating High-Cost Kidney Disease
9. Study tests reliability of more accurate measure of patient pain
10. Follow-Up Tests of Leading Personal Care and Household Cleaning Brands Reveal Improvements in Levels of Carcinogenic 1,4-dioxane
11. Libyan Aid Tests 50-Bed BLU-MED Deployable Field Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New tests provide new insight into why patients are in heart failure
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... International Protein, ... nutritional and bodybuilding supplements, announced it attended the January ECRM trade show in Hilton ... and nutritional scientist who was determined to create a line of products that would ...
(Date:1/20/2017)... ... , ... “Mary Magdalene: Grace is Greater than Sin”: a unique and ... Christ firsthand. “Mary Magdalene: Grace is Greater than Sin” is the creation of published ... with countless women who had little knowledge of the female characters portrayed in the ...
(Date:1/20/2017)... Farmville, NC (PRWEB) , ... January 20, 2017 ... ... the vPEP ® Oscillating Positive Expiratory Pressure (OPEP) device, was featured in ... article by Doug Pursley, MEd, RRT-ACCS, FAARC, “Analysis of Three Oscillating Positive ...
(Date:1/20/2017)... ... 20, 2017 , ... “The Land of More and More”: a brilliant ... hunger, and shares the simple and achievable answer. “The Land of More and More” ... Fairview Missionary Church in Angola, Indiana where he works with the children’s ministry department. ...
(Date:1/19/2017)... ... 19, 2017 , ... Next week after January 20th, the fear for many ... that circumvent health needs of over 30 million. Many interviews with Dr. Carol Francis ... government public servants were suppose to prioritize. Interviews provided below. , Among ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... YORK , Jan. 19, 2017 This ... the current and future scenario of the global market. ... rising opioid consumption. Severe chronic constipation is a major ... to traditional laxatives. Hence, novel targeted therapy has been ... OIC sufferers, launch of targeted medicines, and growing awareness ...
(Date:1/19/2017)... 19, 2017  Stealth BioTherapeutics Inc. ( Stealth ), ... dysfunction, today announced new additions to its senior leadership ... Medical Officer, and Daniel Geffken as interim ... Jim Carr , Pharm.D. has been promoted to Chief ... to welcome Doug and Daniel to our management team, ...
(Date:1/19/2017)... January 19, 2017 According to a study ... is set to witness a CAGR of 6.5% during the forecast ... will continue to be the leading market for cryotherapy globally ... ... emphasizing on ensuring affordable and adequate supply of gas in order ...
Breaking Medicine Technology: